Cyclic Cushing's syndrome

The cyclic Cushing's syndrome is a rare disease characterized by multiple episodes of elevated cortisol levels alternating with periods of its normal secretion. The so-called hypercorticism cycles may be either regular or episodic with intercycle intervals as long as a few days to several years. Most researchers agree that the reliable diagnosis of cyclic Cushing's syndrome should be based on laboratory detection of 3 peaks and 2 falls of plasma cortisol level. Cyclic Cushing's syndrome may be either ACTH dependent or independent. A review of 65 verified cases indicates that this condition may be caused by pituitary corticotropinoma (54%), ectopic ACTH-producing tumour (26%), and adrenal tumour (roughly 11%). The cause of the disease remains uncertain in 9% of the patients. Pathophysiological mechanisms of cyclic Cushing's syndrome are poorly known. In certain cases of bilateral macronodular adrenal hyperplasia or adrenal corticosteroma, it may be associated with the presence of ectopic receptors or anomalous expression of normally located receptors. The majority of the patients presenting with cyclic Cushing's syndrome exhibit symptoms of classical hypercorticism that manifest themselves either on a permanent or cyclic basis. In a small number of patients, clinical signs of cyclic Cushing's syndrome are virtually absent. Variations of the clinical picture and conflicting results of hormonal assays taken together make cyclic Cushing's syndrome difficult to diagnose. Therefore, physicians must be aware of this condition and actively search for it in all patients believed to have an enhanced cortisol production despite normal results of laboratory analysis. Frequent changes of urinary or salivary free cortisol levels are reliable and convenient criteria for cyclic Cushing's syndrome in patients suspected to have this condition. Results of cortisol stimulation or suppression tests are likely to lead to a false conclusion due to spontaneous falls and rises in serum cortisol levels at the time of analysis. Given laboratory confirmation of cyclic Cushing's syndrome, subsequent studies should be focused on the elucidation of its cause. The average life expectancy of patients with cyclic Cushing's syndrome remains to be determined.

cyclic Cushing's syndrome hypercorticism, hypersecretion, cortisol, ACTH, cyclicity, periodicity, secretory peaks and falls, irregular secretion

1. Atkinson A.B. Optimum Strategy for Managing Cyclic Cushing's disease. Meet the professor and case management forum handouts - 91-annual meeting 2009; 22-23.

2. Atkinson A.B., Kennedy A.L., Carson D.J. et al. Five cases of cyclical Cushing's syndrome. Br Med J 1985; 291: 1453-1457.

3. Bailey R.E. Periodic hormonogenesis-a new phenomenon. Periodicity in function of a hormoneproducing tumour in man. J Clin Endocrinol 1971; 32: 317-327.

4. Meinardi J.R., Wolffenbutte B.H.R. and Dullaart R.P.F. Cyclic Cushing's syndrome: a clinical challenge. Eur J Endocrinol 2007; 157: 3: 245-254.

5. Гончаров Н.П., Колесникова Г.С. Кортикостероиды: метаболизм, механизм действия и клиническое применение. М 2002; 17-25.

6. Adachi M., Takayanagi R., Yanase T. et al. Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine. Intern Med 1996; 35: 207-211.

7. Liebowitz G., White A., Hadani M., Gross D.J. Fluctuating hyper-hypocortisolaemia: a variant of Cushing's syndrome. Clin Endocrinol 1997; 46: 759-763.

8. Mosnier-Pudar H., Thomopoulos P., Bertagna X. et al. Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements. Eur J Endocrinol 1995; 133: 313-316.

9. Shapiro M.S., Shenkman L. Variable hormonogenesis in Cushing's syndrome. Quart J Med 1991; 79: 351-363.

10. Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. М 2007; 189.

11. McCance D.R., Gordon D.S., Fannin T.F. et al. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 1993; 38: 79-86.

12. Streeten D.H., Anderson G.H. Jr, Dalakos T., Joachimpillai A.D. Intermittent hypercortisolism: a disorder strikingly prevalent after hypophysial surgical procedures. Endocrine Pract 1997; 3: 123-129.

13. Mantero F., Scaroni C.M., Albiger N.M. Cyclic Cushing's syndrome: an overview. Pituitary 2004; 7: 203-207.

14. Марова Е.И, Беляева А.В., Иловайская И.А. Роль эктопированных рецепторов коры надпочечников в патогенезе АКТГ-независимого синдрома Кушинга. Пробл эндокринол 2008; 1: 40-45.

15. Lacroix A., Ndiaye N., Tremblay J., Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Rev 2001; 22: 75-110.

16. Stewart P.M., Venn P., Heath D.A., Holder G. Cyclical Cushing's syndrome. Br J Hospital Med 1992; 48: 186-187.

17. Yaneva M., Mosnier-Pudar H., Dugue M.A. et al. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 2004; 89: 3345-3351.

18. Stratakis C.A., Sarlis N., Kirschner L.S. et al. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 1999; 131: 8: 585-591.

19. Воронцов А.В. Магнитно-резонансная томография в диагностике патологии гипоталамо-гипофизарной системы и надпочечников: Автореф. дис. … д-ра мед. наук. М 2001; 10-14, 28-30, 34-37.

20. Кадашев Б.А. Аденомы гипофиза. Клиника, диагностика, лечение. М 2007; 82-97, 130-139, 189-250, 301-303, 322-342, 347-352.

21. Ilias I., Torpy D.J., Pacak K. et al. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005; 90: 4955-4962.

22. Hanson J.A., Sohaib S.A., Newell-Price J. et al. Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome. J Clin Endocrinol Metab 1999; 84: 602-605.

23. Kumar J., Spring M., Carrol P.V. et al. 18 Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol 2006; 64: 371-374.

24. Pacak K., Eisenhofer G., Goldstein D.S. Functional imaging of endocrine tumors: role of positron emission tomography. Endocrine Rev 2004; 25: 568-580.

25. Pacak K., Ilias I., Chen C.C. et al. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metabol 2004; 89: 2214-2221.

26. Newell-Price J., Trainer P., Besser M., Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Rev 1998; 19: 647-672.

27. Arnaldi G., Angeli A., Atkinson A.B. et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602.

28. Yanovski J.A., Cutler G.B. Jr, Chrousos G.P., Nieman L.K. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. J Clin Endocrinol Metab 1998; 83: 348-352.

29. Дедов И.И., Мельниченко Г.А., Пронин В.С. и др. Клиника и диагностика эндокринных нарушений. М 2005; 139.

30. Boscaro M., Barzon L., Fallo F., Sonino N. Cushing's syndrome. Lancet 2001; 357: 783-791.

31. Estrada J., Boronat M., Mielgo M. et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. New Engl J Med 1997; 336: 172-177.

32. von Werder K., Muller O.A., Stalla G.K. Somatostatin analogs in ectopic corticotropin production? J Clin Endocrinol Metab 1996; 45: 129-131.

33. Orth D.N. Cushing's syndrome. New Engl J Med 1995; 332: 791-803.